Table 5 Cox multivariate analysis for retinoblastoma patients
From: High expression of TAZ indicates a poor prognosis in retinoblastoma
Variables | SE value | Hazard ratio | Risk ratio (95 % CI) | P Value |
|---|---|---|---|---|
OS | ||||
cTNM stage (III + IV) | 1.065 | 0.085 | 0.011–0.687 | 0.021* |
TAZ high expression | 0.756 | 0.226 | 0.051–0.994 | 0.049* |
PFS | ||||
cTNM stage (III + IV) | 1.097 | 0.030 | 0.003–0.254 | 0.001* |
TAZ high expression | 0.692 | 0.144 | 0.037–0.559 | 0.005* |
LRRFS | ||||
cTNM stage (III + IV) | 1.062 | 0.056 | 0.007–0.452 | 0.007* |
TAZ high expression | 0.710 | 0.195 | 0.049–0.783 | 0.021* |
DMFS | ||||
cTNM stage (III + IV) | 1.058 | 0.084 | 0.011–0.672 | 0.019* |
+TAZ high expression | 0.735 | 0.228 | 0.054–0.960 | 0.044* |